These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21401869)

  • 1. Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts.
    Riella LV; Watanabe T; Sage PT; Yang J; Yeung M; Azzi J; Vanguri V; Chandraker A; Sharpe AH; Sayegh MH; Najafian N
    Am J Transplant; 2011 Apr; 11(4):832-40. PubMed ID: 21401869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
    Tanaka K; Albin MJ; Yuan X; Yamaura K; Habicht A; Murayama T; Grimm M; Waaga AM; Ueno T; Padera RF; Yagita H; Azuma M; Shin T; Blazar BR; Rothstein DM; Sayegh MH; Najafian N
    J Immunol; 2007 Oct; 179(8):5204-10. PubMed ID: 17911605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
    Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
    Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
    Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH
    J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the B7 costimulatory pathway in allograft rejection.
    Pearson TC; Alexander DZ; Corbascio M; Hendrix R; Ritchie SC; Linsley PS; Faherty D; Larsen CP
    Transplantation; 1997 May; 63(10):1463-9. PubMed ID: 9175811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
    J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival.
    Szot GL; Zhou P; Sharpe AH; He G; Kim O; Newell KA; Bluestone JA; Thistlethwaite JR
    Transplantation; 2000 Mar; 69(5):904-9. PubMed ID: 10755548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.
    Grazia TJ; Plenter RJ; Doan AN; Kelly BP; Weber SM; Kurche JS; Cushing SO; Gill RG; Pietra BA
    Transplantation; 2007 Jun; 83(11):1449-58. PubMed ID: 17565318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses.
    Yamaura K; Watanabe T; Boenisch O; Yeung M; Yang S; Magee CN; Padera R; Datta S; Schatton T; Kamimura Y; Azuma M; Najafian N
    Am J Transplant; 2010 Oct; 10(10):2355-62. PubMed ID: 21143433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.
    Fiorina P; Jurewicz M; Vergani A; Petrelli A; Carvello M; D'Addio F; Godwin JG; Law K; Wu E; Tian Z; Thoma G; Kovarik J; La Rosa S; Capella C; Rodig S; Zerwes HG; Sayegh MH; Abdi R
    J Immunol; 2011 Jan; 186(1):121-31. PubMed ID: 21131428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of chimeric hearts: a tool for testing the "passenger leukocyte" hypothesis.
    Eiref SD; Zhang W; Popma SH; Shah LJ; Moore JS; Rosengard BR
    Ann Thorac Surg; 1997 Sep; 64(3):628-33. PubMed ID: 9307449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A link between PDL1 and T regulatory cells in fetomaternal tolerance.
    Habicht A; Dada S; Jurewicz M; Fife BT; Yagita H; Azuma M; Sayegh MH; Guleria I
    J Immunol; 2007 Oct; 179(8):5211-9. PubMed ID: 17911606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.